Lv2
160 积分 2025-03-01 加入
14-day versus 28-day trifluridine–tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
1小时前
已完结
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis
8个月前
已完结
ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer
9个月前
已完结